Ranbaxy to raise up to $1.5 bn, list in US
9th Sep 2005, 22:23 GMT
The board of Ranbaxy Laboratories Ltd on Friday approved a proposal to raise up to $1.5 billion through convertible bonds or global depository receipts. It also cleared a plan to list in the United States of America by converting existing GDRs into American depository receipts or by issuing fresh shares.
Latest news from The Financial Express:
- Zee bags Ten Sports in Rs 256-crore deal
- Maran assures Tata of level field
- Kidnapping shocks IT industry
- No market economy status for China now
- Air fares set to rise 3%-5% tomorrow
- Templeton buys Rajan Raheja out of joint venture
- Orascom likely to pare stake in Hutch Telecom
- Dr Reddys to raise Rs 1,200 cr via ADS
- DLF settles dispute with minority investors
- Bank loans to risky sectors rise 19%